Value of in-vitro diagnostic substance manufacturing shipments 1998-2011

Value of U.S. in-vitro diagnostic substance manufacturing shipments from 1998 to 2011 (in million U.S. dollars)

by Statista Research Department, last edited May 1, 2013
Value of in-vitro diagnostic substance manufacturing shipments 1998-2011 This statistic shows the value of U.S. in-vitro diagnostic substance manufacturing shipments from 1998 to 2011. In 1998, this industry's shipments were valued at approximately 8.9 billion U.S. dollars.
Show more

Value of U.S. in-vitro diagnostic substance manufacturing shipments from 1998 to 2011 (in million U.S. dollars)

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Canadian pharmaceutical industry"
  • Global positioning
The most important statistics
  • Key figures
  • Regional comparison
  • Generics
  • Products and prices
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: You might find this interesting as well
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.